专利检索 ap:("ALNYLAM PHARMACEUTICALS, INC.") AND inv:"BHAUMIK A. PANDYA" 第 1 页

1.

发明申请
COMPOSITIONS AND METHODS FOR SILENCING VEGF-A EXPRESSION 有权

公开(公告)号：US20230136787A1

公开(公告)日：2023-05-04

申请号：US17798156

申请日：2021-02-09

申请人： ALNYLAM PHARMACEUTICALS, INC.

发明人： JAMES D. MCININCH , MARK KEATING , MARK K. SCHLEGEL , ADAM CASTORENO , VASANT R. JADHAV , CHARALAMBOS KAITTANIS , ELENA CASTELLANOS-RIZALDOS , BHAUMIK A. PANDYA

IPC分类号： C12N15/113 , A61P27/02 , A61K45/06

摘要： The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting VEGF-A, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of VEGF-A.

2.

发明公开
Compositions and Methods for Silencing MYOC Expression 审中-公开

公开(公告)号：US20240318175A1

公开(公告)日：2024-09-26

申请号：US18572486

申请日：2022-06-28

申请人： ALNYLAM PHARMACEUTICALS, INC.

发明人： ADAM CASTORENO , BHAUMIK A. PANDYA , ELENA CASTELLANOS-RIZALDOS , MARK K. SCHLEGEL , VASANT R. JADHAV

IPC分类号： C12N15/113 , A61K9/00 , A61K45/06 , A61P27/06

CPC分类号： C12N15/113 , A61K9/0048 , A61K45/06 , A61P27/06 , C12N2310/11 , C12N2310/3125 , C12N2310/313 , C12N2310/3513 , C12N2310/3515 , C12N2310/533 , C12N2320/32

摘要： The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting MYOC, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of MYOC.